D-0520-2026 Class II Ongoing
FDA drug recall D-0520-2026 was initiated by JB Chemicals And Pharmaceuticals Ltd on Apr 23, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test The recall status is ongoing. Affected quantity: 675 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 13, 2026
- Initiation Date
- Apr 23, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 675 bottles
Product description
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Distribution pattern
Nationwide in the USA
Code information
Lot #: GEH25023, Expires: 6/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0520-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026